L
LB Pharmaceuticals Inc (LBRX)
NGM – Real vaqt narxi. Valyuta: USD
31.92
+0.92 (2.97%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
32.19
+0.27 (0.85%)
Bozordan keyin: Jun 26, 2026, 7:16 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
31.92
+0.92 (2.97%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
32.19
+0.27 (0.85%)
Bozordan keyin: Jun 26, 2026, 7:16 PM EDT
LB Pharmaceuticals Inc, klinik bosqichdagi biofarmatsevtika kompaniyasi, shizofreniya, bipolyar depressiya va boshqa neyropsixiatrik kasalliklarni davolash uchun terapiyalarni ishlab chiqadi. Uning asosiy mahsuloti LB-102, kichik molekulali og'iz orqali qabul qilinadigan preparat bo'lib, u o'tkir shizofreniyani davolash uchun 3-faza klinik sinovidan o'tmoqda; bipolyar I depressiyasini davolash uchun 2-faza klinik sinovini yakunlagan; KBD (Katta Bipolyar Depressiya)ga qo'shimcha davolash; va LAI (uzoq muddatli in'ektsiya) formulani ishlab chiqish uchun preklinik bosqichda. Kompaniya 2015 yilda ro'yxatga olingan va Nyu-York, Nyu-Yorkda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. James Rawls Pharm.D. | Senior Vice President of Regulatory Affairs |
| Dr. Richard A. Silva Ph.D. | Senior Vice President of Technical Operations |
| Mr. Gad Soffer | Chief Operating & Business Officer |
| Mr. Marc L. Panoff CPA | Senior Vice President of Finance |
| Ms. Ellen Rose | Senior Vice President of Corporate Affairs |
| Ms. Heather D. Turner Esq., J.D. | CEO & Director |
| Ms. Kaya Pai Panandiker Kamlesh | Chief Commercial Officer |
| Ms. Lindsay Beaupre | Senior VP of People & Culture |
| Ms. Minako Pazdera J.D., Ph.D. | General Counsel |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-10 | 8-K | d221514d8k.htm |
| 2026-06-09 | 8-K | d138757d8k.htm |
| 2026-05-12 | 8-K | d134118d8k.htm |
| 2026-04-23 | DEFA14A | d269343ddefa14a.htm |
| 2026-04-23 | ARS | d269750dars.pdf |
| 2026-04-10 | CORRESP | filename1.htm |
| 2026-04-06 | S-1 | d115802ds1.htm |
| 2026-03-26 | S-8 | d139369ds8.htm |
| 2026-03-26 | 8-K | d129775d8k.htm |
| 2026-03-16 | 8-K | d105454d8k.htm |